Angelo Santoliquido
Catholic University of the Sacred Heart
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Angelo Santoliquido.
Journal of Hepatology | 2009
M.A. Zocco; Enrico Di Stasio; Raimondo De Cristofaro; M. Novi; M.E. Ainora; Francesca Romana Ponziani; Laura Riccardi; Stefano Lancellotti; Angelo Santoliquido; Roberto Antonio Flore; Maurizio Pompili; Gian Ludovico Rapaccini; Paolo Tondi; Giovanni Gasbarrini; Raffaele Landolfi; Antonio Gasbarrini
BACKGROUND/AIMS Prognostic scores currently used in cirrhotic patients do not include thrombotic risk factors (TRFs). Predicting factors of portal vein thrombosis (PVT) development are still unknown. We wanted to describe TRFs as a function of liver disease severity using the MELD score and assess the role of local and systemic TRFs as predictors of PVT development in cirrhotic patients. METHODS One hundred consecutive patients with liver cirrhosis were included in the study. TRFs, D-dimers, MELD score, portal vein patency and flow velocity were evaluated in all subjects at baseline and every 6 months thereafter. Variables able to predict PVT development within 1 year were identified by means of multiple logistic regression. RESULTS The plasma levels of protein C and antithrombin were lower and the concentration of D-dimers was higher in patients with advanced disease. Plasma levels of antithrombin, protein C and protein S resulted significantly lower in PVT group at univariate analysis, but reduced portal vein flow velocity was the only variable independently associated with PVT development. CONCLUSIONS Lower concentrations of natural coagulation inhibitors are frequently detected in patients with liver cirrhosis. A reduced portal flow velocity seems to be the most important predictive variable for PVT development in patients with cirrhosis.
Alimentary Pharmacology & Therapeutics | 2005
Gabriella Nucera; Maurizio Gabrielli; Andrea Lupascu; Ernesto Cristiano Lauritano; Angelo Santoliquido; Filippo Cremonini; Giovanni Cammarota; Paolo Tondi; Paolo Pola; Giovanni Gasbarrini; Antonio Gasbarrini
Background : Small intestinal bacterial overgrowth and sugar malabsorption (lactose, fructose, sorbitol) may play a role in irritable bowel syndrome. The lactulose breath test is a reliable and non‐invasive test for the diagnosis of small intestinal bacterial overgrowth. The lactose, fructose and sorbitol hydrogen breath tests are widely used to detect specific sugar malabsorption.
Alimentary Pharmacology & Therapeutics | 2005
Andrea Lupascu; Maurizio Gabrielli; Ernesto Cristiano Lauritano; Emidio Scarpellini; Angelo Santoliquido; Giovanni Cammarota; Roberto Antonio Flore; Paolo Tondi; Paolo Pola; Giovanni Gasbarrini; Antonio Gasbarrini
Background: Studies assessing the prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome gave contrasting results. Differences in criteria to define irritable bowel syndrome patients and methods to assess small intestinal bacterial overgrowth may explain different results. Moreover, no data exist on small intestinal bacterial overgrowth prevalence in a significant population of healthy non‐irritable bowel syndrome subjects.
Alimentary Pharmacology & Therapeutics | 2005
Ernesto Cristiano Lauritano; Maurizio Gabrielli; Andrea Lupascu; Angelo Santoliquido; Gabriella Nucera; Emidio Scarpellini; Vincenti F; Giovanni Cammarota; Roberto Antonio Flore; Paolo Pola; Giovanni Gasbarrini; Antonio Gasbarrini
Background : Few controlled studies assessing choice and duration of antibiotic therapy for small intestinal bacterial overgrowth are available.
Alimentary Pharmacology & Therapeutics | 2005
Alfredo Papa; Angelo Santoliquido; Silvio Danese; Marcello Covino; C. Di Campli; Riccardo Urgesi; Antonino Grillo; S. Guglielmo; Paolo Tondi; Luisa Guidi; I. De Vitis; G Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Background : Patients with inflammatory bowel disease have an increased risk of thrombotic complications; moreover, mesenteric microvascular thrombosis has been hypothesized as a contributing factor in the pathogenesis of inflammatory bowel disease.
Journal of Bone and Joint Surgery, American Volume | 2004
Enrico Pola; Pierangelo Papaleo; Angelo Santoliquido; G. Gasparini; Lorenzo Aulisa; Ernesto De Santis
BACKGROUND The aim of this study was to identify clinical factors associated with an increased need for perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. METHODS We evaluated eighty-five consecutive nonanemic patients who underwent elective, unilateral, cementless, primary total hip arthroplasty and met our inclusion criteria. We attempted to determine whether clinical parameters influencing perioperative blood loss, such as age, gender, hypertension, and body mass index, were also associated with the need for perioperative blood transfusion. RESULTS Perioperative blood transfusion was required in twenty-four (28%) of the eighty-five nonanemic patients. When considered alone, age, gender, hypertension, and body mass index were not significantly associated with an increased risk of perioperative blood transfusion, on the basis of the numbers available. In contrast, there was a significantly increased risk of blood transfusion when two or more of these clinical parameters were present (p = 0.02). CONCLUSIONS Our findings indicate that clinical variables such as age, gender, hypertension, and body mass index may have a synergistic effect on the risk of transfusion in patients undergoing elective total hip arthroplasty. The simultaneous analysis of these parameters might help to stratify patients with different risks for transfusion and may increase the efficiency and reduce the cost of blood-ordering practices associated with total hip arthroplasty. LEVEL OF EVIDENCE Prognostic study, Level II-1 (retrospective study). See Instructions to Authors for a complete description of levels of evidence.
American Journal of Cardiology | 1999
Michele Serricchio; Mario Gaudino; Paolo Tondi; Antonio Gasbarrini; Laura Gerardino; Angelo Santoliquido; Paolo Pola; Gianfederico Possati
Five years after surgery the echo-Doppler characteristics of the forearm circulation and the transcutaneous oxygen and carbon dioxide pressures of the operated and control arm were determined at rest and under conditions of hand exercise in 34 patients who received a radial artery graft for myocardial revascularization. Doppler measurements showed the ulnar compensation to radial artery removal, and transcutaneous measurements demonstrated a moderate degree of exercise-induced hand ischemia on the operated site.
Digestive Diseases and Sciences | 1998
Antonio Gasbarrini; I Massari; Michele Serricchio; Paolo Tondi; Annetta De Luca; Francesco Franceschi; Veronica Ojetti; Antonio Dal Lago; Roberto Antonio Flore; Angelo Santoliquido; Giovanni Gasbarrini; Paolo Pola
Raynauds phenomenon is defined by anintermittent vasospasm of the arterioles of the distallimbs. Helicobacter pylori infection has been recentlyassociated with Raynauds phenomenon. The aim of this study was to assess the effects of H. pylorieradication on Raynauds attacks. Forty-six patientsaffected by primary Raynauds phenomenon were evaluated.H. pylori infection was assessed by [13C]urea breath test. Eradication therapy was given toinfected patients for seven days. Discomfort and theduration and frequency of attacks of Raynaudsphenomenon per week were assessed. Thirty-six subjectswere infected with H. pylori; the bacterium waseradicated in 83% of these after therapy. Attacks ofRaynauds phenomenon completely disappeared in 17% ofthe patients with H. pylori eradication. Discomfort and the duration and frequency of attacks ofRaynauds phenomenon were significantly reduced in 72%of the remaining patients. Conversely, attacks ofRaynauds disease did not change significantly during the 12-week follow-up period either in the H.pylori-negative patients or in the infected subjects inwhom the bacterium was not eradicated by therapy. Thestudy shows that H. pylori eradication causes a significant decrease in clinical attacks ofRaynauds disease. The reduction of vasoactivesubstances determined by the eradication of thebacterium may be the pathogenetic mechanism underlyingthe phenomenon.
The Journal of Thoracic and Cardiovascular Surgery | 2003
Mario Gaudino; Paolo Tondi; Michele Serricchio; Paola Spatuzza; Angelo Santoliquido; Roberto Flora; Fabiana Girola; Giuseppe Nasso; Paolo Pola; Gianfederico Possati
BACKGROUND The radial artery has recently been proposed as an alternative arterial conduit for surgical myocardial revascularization. This study was conceived to evaluate the degree of atherosclerotic involvement of the radial artery in patients with coronary artery disease and the eventual influence of a subtle degree of preoperative atherosclerosis on the midterm results of radial artery grafts. METHODS AND RESULTS The intima-media thickness of the radial artery, common carotid artery, and internal thoracic artery was evaluated in 42 coronary artery disease patients and in 26 control patients. All radial arteries were then used for myocardial revascularization; 30 patients submitted to control angiography after 5 years. The mean intima-media thickness was 0.92 +/- 0.22 mm for the common carotid artery, 0.54 +/- 0.16 mm for the internal thoracic artery, 0.55 +/- 0.11 mm for the radial artery in coronary artery disease patients versus 0.79 +/- 0.14 mm, 0.52 +/- 0.11 mm, and 0.56 +/- 0.09 mm, respectively, in control patients (P =.001 only for the common carotid artery). No correlation was found between the intima-media thickness of the carotid, internal thoracic, and radial artery. No correlation was found between the preoperative intima-media thickness of the radial artery and the midterm patency and endothelial-mediated vasodilating capacity of radial artery grafts. CONCLUSION In coronary artery disease patients, radial artery atherosclerotic involvement is more frequent than that of the gold standard internal thoracic artery but still by far less severe than that of the common carotid artery. The early atherosclerotic signs often observed in the radial artery do not seem to have the potential to influence radial artery graft patency and endothelial function.
Alimentary Pharmacology & Therapeutics | 2004
Luca Santarelli; Maurizio Gabrielli; Filippo Cremonini; Angelo Santoliquido; Marcello Candelli; E.C. Nista; Paolo Pola; Giovanni Gasbarrini; Antonio Gasbarrini
Background : Hyperhomocysteinaemia is an independent risk factor for atherosclerosis. It is often related to low levels of vitamin B12 and/or folate, enzymatic co‐factors of methionine metabolism. Atrophic gastritis, often caused by Helicobacter pylori infection, may impair vitamin absorption.